共 37 条
Blockade of extracellular heat shock protein 90α by 1G6-D7 attenuates pulmonary fibrosis through inhibiting ERK signaling
被引:35
|作者:
Dong, Hangming
[1
]
Luo, Lishan
[1
,2
]
Zou, Mengchen
[1
]
Huang, Chaowen
[1
]
Wan, Xuan
[1
]
Hu, Yahui
[1
]
Le, Yanqing
[1
]
Zhao, Haijin
[1
]
Li, Wei
[3
,4
]
Zou, Fei
[5
]
Cai, Shaoxi
[1
]
机构:
[1] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Guangzhou 510515, Guangdong, Peoples R China
[2] Huizhou Municipal Cent Hosp, Dept Resp Med, Huizhou, Peoples R China
[3] Univ Southern Calif, Keck Med Ctr, Dept Dermatol, Los Angeles, CA USA
[4] Univ Southern Calif, Keck Med Ctr, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[5] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China
基金:
中国国家自然科学基金;
关键词:
1G6-D7;
extracellular Hsp90 alpha;
pulmonary fibrosis;
fibroblast activation;
ECM synthesis;
SKIN CELL-MIGRATION;
HSP90;
RECEPTOR;
HSP90-ALPHA;
MOTILITY;
HYPOXIA;
PATHOGENESIS;
PUBLICATION;
MECHANISMS;
SECRETION;
D O I:
10.1152/ajplung.00489.2016
中图分类号:
Q4 [生理学];
学科分类号:
071003 ;
摘要:
Pulmonary fibrosis is characterized by lung fibroblast activation and ECM deposition and has a poor prognosis. Heat shock protein 90 (Hsp90) participates in organ fibrosis, and extracellular Hsp90 alpha (eHsp90 alpha) promotes fibroblast activation and migration. This study aimed to investigate whether a selective anti-Hsp90 alpha monoclonal antibody, 1G6-D7, could attenuate lung fibrosis and whether 1G6-D7 presents a protective effect by inactivating the profibrotic pathway. Our results showed that eHsp90 alpha was increased in mice with BLM-induced pulmonary fibrosis and that 1G6-D7 attenuated inflammation and collagen deposition in the lung. TGF-beta 1 induced eHsp90 alpha secretion, concomitantly promoting HFL-1 activation and ECM synthesis. 1G6-D7-mediated inhibition of eHsp90 alpha significantly blocked these effects, meanwhile inhibiting downstream profibrotic pathways such as ERK, Akt, and P38. Human recombinant (hr) Hsp90 alpha mimicked the effects of TGF-beta 1, by activating profibrotic pathways and by upregulating LRP-1. Moreover, ERK inhibition effectively blocked the effect of (hr) Hsp90 alpha. In conclusion, 1G6-D7 significantly protects against BLM-induced pulmonary fibrosis by ameliorating fibroblast activation and ECM production, which may be through blocking ERK signaling. Our results suggest a safer molecular therapy, 1G6-D7, in pulmonary fibrosis.
引用
收藏
页码:L1006 / L1015
页数:10
相关论文